274 related articles for article (PubMed ID: 24833099)
1. Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.
Yin H; Zhou W; Meng J; Zhang D; Wu Z; Wang T; Wang J; Wang P; Shi X; Wu S; Zhao J; Xiao J
Ann Surg Oncol; 2014 Oct; 21(11):3572-8. PubMed ID: 24833099
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.
Meng T; Yin H; Li B; Li Z; Xu W; Zhou W; Cheng M; Wang J; Zhou L; Yang X; Liu T; Yan W; Song D; Xiao J
Neuro Oncol; 2015 May; 17(5):725-32. PubMed ID: 25488908
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center.
Xu W; Li X; Huang W; Wang Y; Han S; Chen S; Xu L; Yang X; Liu T; Xiao J
Ann Surg Oncol; 2013 Mar; 20(3):804-10. PubMed ID: 23096699
[TBL] [Abstract][Full Text] [Related]
4. Chondrosarcoma of the mobile spine: a review of 21 cases treated at a single center.
Schoenfeld AJ; Hornicek FJ; Pedlow FX; Kobayashi W; Raskin KA; Springfield D; DeLaney TF; Nielsen GP; Mankin HJ; Schwab JH
Spine (Phila Pa 1976); 2012 Jan; 37(2):119-26. PubMed ID: 22037533
[TBL] [Abstract][Full Text] [Related]
5. Chondrosarcoma of bone: a statistical analysis of prognostic factors.
Wang JW; Ger LP; Shih CH; Hsieh MC
J Formos Med Assoc; 1991 Oct; 90(10):998-1003. PubMed ID: 1685183
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center.
Wan W; Lou Y; Hu Z; Wang T; Li J; Tang Y; Wu Z; Xu L; Yang X; Song D; Xiao J
J Neurooncol; 2017 Jan; 131(2):313-320. PubMed ID: 27752884
[TBL] [Abstract][Full Text] [Related]
7. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
8. Treatment and outcome of primary aggressive giant cell tumor in the spine.
Yin H; Yang X; Xu W; Li B; Li B; Wang T; Meng T; Wang P; Liu T; Zhou W; Xiao J
Eur Spine J; 2015 Aug; 24(8):1747-53. PubMed ID: 25631339
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases.
Bergh P; Gunterberg B; Meis-Kindblom JM; Kindblom LG
Cancer; 2001 Apr; 91(7):1201-12. PubMed ID: 11283918
[TBL] [Abstract][Full Text] [Related]
10. Locally recurrent chondrosarcoma of the pelvis and limbs can only be controlled by wide local excision.
Laitinen MK; Parry MC; Le Nail LR; Wigley CH; Stevenson JD; Jeys LM
Bone Joint J; 2019 Mar; 101-B(3):266-271. PubMed ID: 30813783
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of traditional clinical parameters and inflammatory biomarkers for the prognosis of patients with spinal chondrosarcoma: a retrospective study of 150 patients in a single center.
Xu K; Li B; Huang Q; Jiang D; Sun H; Zhong N; Wan W; Wei H; Xiao J
Eur Spine J; 2019 Jun; 28(6):1468-1479. PubMed ID: 31055664
[TBL] [Abstract][Full Text] [Related]
12. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of the prognosis of 37 chondrosarcoma patients.
Yang ZM; Tao HM; Ye ZM; Li WX; Lin N; Yang DS
Asian Pac J Cancer Prev; 2012; 13(4):1171-6. PubMed ID: 22799300
[TBL] [Abstract][Full Text] [Related]
14. Oncologic impact of the curettage of grade 2 central chondrosarcoma of the extremity.
Cho WH; Song WS; Jeon DG; Kong CB; Koh JS; Kim JI; Lee SY
Ann Surg Oncol; 2011 Dec; 18(13):3755-61. PubMed ID: 21611858
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of Primary and Recurrent Chondrosarcoma of the Rib.
Roos E; van Coevorden F; Verhoef C; Wouters MW; Kroon HM; Hogendoorn PC; van Houdt WJ
Ann Surg Oncol; 2016 Mar; 23(3):811-7. PubMed ID: 26498768
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study.
Andreou D; Gilg MM; Gosheger G; Werner M; Hardes J; Pink D; Leithner A; Tunn PU; Streitbürger A
Ann Surg Oncol; 2016 Jan; 23(1):120-5. PubMed ID: 26350369
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features and Prognostic Factors of Patients With Nerve Sheath Tumors in the Cervical Spine.
Li B; Yin H; Meng T; Zhou P; Han Z; Jia Q; Cai W; Han S; Wang T; Chen T; Zhou W; Xiao J
Spine (Phila Pa 1976); 2016 Oct; 41(20):E1208-E1215. PubMed ID: 27043192
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and survival in conventional chondrosarcoma: A single institution review.
Chen YC; Wu PK; Chen CM; Tsai SW; Chen CF; Chen WM
J Chin Med Assoc; 2020 Jul; 83(7):669-673. PubMed ID: 32221156
[TBL] [Abstract][Full Text] [Related]
19. The treatment of locally recurrent chondrosarcoma: Is extensive further surgery justified?
Streitbuerger A; Ahrens H; Gosheger G; Henrichs M; Balke M; Dieckmann R; Hardes J
J Bone Joint Surg Br; 2012 Jan; 94(1):122-7. PubMed ID: 22219259
[TBL] [Abstract][Full Text] [Related]
20. Survival and prognostic factors in conventional G1 chondrosarcoma.
Fromm J; Klein A; Baur-Melnyk A; Knösel T; Lindner L; Birkenmaier C; Roeder F; Jansson V; Dürr HR
World J Surg Oncol; 2019 Sep; 17(1):155. PubMed ID: 31481076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
